NEOT.494.HUGE ALERT.A NASDAQ PHARMA CO.WAS $2.52 IN MAY.BOOK VALUE $1.36.May 30 2017 2.5199999 2.4932 -0.01 -0.27% 2.48 2.5352001 30,386 CHECK DD BELOW.THIS THING WILL SEE A MINIMUM $1.36 BOOK VALUE PRICE IMO. HUGE CASH ON HAND. As of April 28, 2017, the registrant had 13,831,747 shares of common stock INSIDERS HAVE NOT SOLD SHARES SINCE 2015. Total stockholders’ equity $9,035,445 Cash equivalentend of period $9,843,138 Ownership Summary as reported in the most recent 13F filings http://www.nasdaq.com/symbol/neot/institutional-holdings/sold-out Institutional Ownership 12.17% Total Shares Outstanding (millions) 14 Total Value of Holdings (millions) $1
Active Positions
HOLDERS SHARES Increased Positions 10 115,562 Decreased Positions 4 23,334 Held Positions 5 1,544,836 Total Institutional Shares 19 1,683,732 New and Sold Out Positions Total ActiveShares New/SoldShares 0k 100k -100k 200k HOLDERS SHARES New Positions 6 76,567 Sold Out Positions 1 18,300 SAN DIEGO, July 10, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) announced today that its Board of Directors has unanimously approved plans to initiate a process to explore and review a range of strategic alternatives focusing on seeking an acquisition, business combination or partnership that will allow for it to maximize shareholder value from its remaining assets and cash resources. Neothetics has engaged Oppenheimer and Co., Inc. to act as its exclusive financial advisor to the company and Board for this process. The Company also intends to streamline its operations in order to preserve its capital and cash resources, including implementing a reduction in workforce.
“We have unanimously determined that seeking a strategic transaction gives us the best opportunity to maximize shareholder value,” said Kim Kamdar, Ph.D., a member of Neothetics’ Operating Committee and Board of Directors. “In addition, we continue to review all operational expenses in order to facilitate our ability to enter into a strategic transaction.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.